The portfolio maintains a cost advantage over competitors, priced within the lowest fee quintile among peers.
SPDR® S&P Biotech ETF XBI
Morningstar’s Analysis XBI
Will XBI outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 12.6
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Alpine Immune Sciences Inc | 1.87 | 124.0 Mil | Healthcare |
Revolution Medicines Inc Ordinary Shares | 1.28 | 84.4 Mil | Healthcare |
Biomarin Pharmaceutical Inc | 1.22 | 80.4 Mil | Healthcare |
Exact Sciences Corp | 1.20 | 79.4 Mil | Healthcare |
Exelixis Inc | 1.19 | 78.7 Mil | Healthcare |
Moderna Inc | 1.19 | 78.6 Mil | Healthcare |
Crinetics Pharmaceuticals Inc | 1.19 | 78.5 Mil | Healthcare |
Roivant Sciences Ltd Ordinary Shares | 1.16 | 76.9 Mil | Healthcare |
Natera Inc | 1.16 | 76.8 Mil | Healthcare |
Cerevel Therapeutics Holdings Inc Ordinary Shares | 1.16 | 76.4 Mil | Healthcare |